SCA Biohaven Ataxia Clinical Trial Eligibility Form

JavaScript isn't enabled in your browser, so this file can't be opened. Enable and reload.

SCA Biohaven Ataxia Clinical Trial Eligibility Form

The Duke Movement Disorders Clinic and Biohaven Pharmaceuticals are conducting a clinical trial for a medication for some inherited (genetic) forms of spinocerebellar ataxia (SCA), specifically SCA1, 2, 3, 7, and 10. No other forms of SCA are being considered for this trial.

This short form will help us determine whether you are eligible to participate in this trial.

Sign in to Google to save your progress. Learn more

* Indicates required question

Email *

Your email

This trial would involve visits to the Duke Movement Disorders Clinic over nearly two years. Would you be able to visit the clinic during a two-year period? *

Yes

No

Next

Clear form

Never submit passwords through Google Forms.

This content is neither created nor endorsed by Google. Report Abuse - Terms of Service - Privacy Policy